Drugs / Treg infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00602693 | Jul 2007 → Sep 2014 | leukemia, myelodysplastic syndrome, plasma cell myeloma | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Treg infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00602693 ↗ |
| Modality | Cell therapy | “Infusion of T regulatory cells” NCT00602693 ↗ |
| Route | Intravenous | “UCB-derived CD4+ CD25+ Treg cells IV” NCT00602693 ↗ |